Premium
Pharmacogenetic diversification by alternative translation initiation: background channels to the fore: Commentary on Kisselbach et al ., Br J Pharmacol 171: 5182–5194
Author(s) -
Abbott G W
Publication year - 2015
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/bph.12630
Subject(s) - translation (biology) , pharmacogenetics , medicine , pharmacology , biology , messenger rna , biochemistry , genotype , gene
Linked Article This article is a Commentary on Kisselbach J, Seyler C, Schweizer PA, Gerstberger R, Becker R, Katus HA and Thomas D (2014). Modulation of K2P2.1 and K2P10.1 K+ channel sensitivity to carvedilol by alternative mRNA translation initiation. Br J Pharmacol 171: 5182–5194. doi: 10.1111/bph.12596